Basel Medical (BMGL) EPS (Basic) (2023 - 2024)

Basel Medical recorded quarterly EPS (Basic) of -$0.01 in Q4 2024, down 109.33% quarter-over-quarter from $0.16 in Q4 2023, and down 109.33% year-over-year from $0.16 in Q1 2024.

Basel Medical's EPS (Basic) history runs 2 years deep, the most recent figure standing at -$0.01 for Q4 2024.

  • In Q4 2024, EPS (Basic) fell 109.33% year-over-year to -$0.01; the TTM figure through Jun 2025 stood at $0.14 (changed N/A YoY), while the FY2025 annual figure was -$0.45, down 568.33% from the prior year.
  • EPS (Basic) came in at -$0.01 for Q4 2024 at Basel Medical, down from $0.16 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.16 in Q4 2023 to a low of -$0.01 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 7.25
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 8.09
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 2.93
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 1.96
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 1.73
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 5.71
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 0.20
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 4.85
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 0.51
10 Basel Medical 8.57 Mn 6.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -0.01
Dec 31, 2023 0.16